Industries > Pharma > Global Biomarkers Market Forecast 2017-2027

Global Biomarkers Market Forecast 2017-2027

Biomarker Services, Biomarker Diagnostics, Biomarker Discovery, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS, Autoimmune Diseases

PUBLISHED: 18 October 2017
PAGES: 206
PRODUCT CODE: PHA0248

Clear
WOOCS 2.2.1

The global biomarkers market is expected to grow at a CAGR of 9.1% in the first half of the forecast period. In 2016, the largest sector of the market was biomarker discovery, which encompasses revenues for instruments and reagents, as well as the other costs associated with in-house biomarker research and development. This sector accounted for 49.3% of the global biomarkers market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 206-page report you will receive 66 tables and 59 figures– all unavailable elsewhere.

The 206-page report provides clear detailed insight into the global biomarkers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Biomarkers Market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the global biomarkers market by Sector:
– Biomarker Services
– Biomarker Diagnostics
– Biomarker Discovery

• This report also breaks down the revenue forecast for the global biomarkers market by Discipline:
– Genomics
– Proteomics
– Bioinformatics
– Other

• This report also breaks down the revenue forecast for the global biomarkers market by Therapeutic Indication:
– Cancer
– Cardiovascular Diseases
– CNS,
– Autoimmune Diseases
– Other

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– EU5 (further segmented into France, Germany, the UK, Spain and Italy)
– Japan
– China
– India
– Russia
– Brazil
– RoW

Global Biomarkers Market Forecast 2017-2027

• Our study gives qualitative analysis of the biomarkers market. It includes a SWOT and STEP Analysis.

• Our study discusses the selected leading companies that are the major players in the biomarkers industry. These companies are biomarker service providers, biomarker technology providers and biomarker diagnostic developers:
– Quintiles IMS Holdings Inc
– Laboratory Corporation of America Holdings
– Parexel
– Charles River Laboratories
– ICON plc
– WuXi PharmaTec
– Caprion Proteomics
– Proteome Sciences
– Pacific Biomarkers
– Oxford Gene Technology (OGT)
– Worldwide Clinical Trials (WWC)
– Agilent
– AB SCIEX
– QIAGEN
– Axela Inc
– Thermo Fisher Scientific
– Quest Diagnostics
– Myriad Genetics
– Genomic Health
– Critical Diagnostics
– Epigenomics
– MDxHealth (formerly OncoMethylome)

• Our study also discusses activities of the big pharmaceutical companies that are investing in biomarkers development through, for example, collaborations with CROs:
– Pfizer
– Novartis
– Roche Diagnostics
– Ventana Medical Systems
– Merck & Co.
– Sanofi
– GSK
– Abbott Laboratories
– AstraZeneca

Visiongain’s study is intended for anyone requiring commercial analyses for the global biomarkers market. You find data, trends and predictions.

Buy our report today Global Biomarkers Market Forecast 2017-2027: Biomarker Services, Biomarker Diagnostics, Biomarker Discovery, Genomics, Proteomics, Bioinformatics, Cancer, Cardiovascular Diseases, CNS, Autoimmune Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Biomarkers Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Biomarkers Market Forecast 2017-2027


Latest Pharma news

Pharmaceutical CDMO Services on the Rise

The pharmaceutical market is one of today’s fastest-growing industries, which is why the professionals from Visiongain have made it their business to help companies and stakeholders stay up to date. One sector experiencing significant growth is that of contract development and manufacturing organization (CDMO) services. Here you’ll find all you need to know about this fast-growing sector of the pharmaceutical …

24 February 2020

READ

“Global Cell Therapy Technologies market set to grow to $23bn by 2024” says new Visiongain report

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burdens and the need for more personalised & precision medicine has led to massive growth in the cell technology market, which is likely to increase over the next decade.

19 February 2020

READ

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

READ

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

READ

Categories